童0731
Lv2
130 积分
2022-08-23 加入
-
Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies
6天前
已关闭
-
Lipid Peroxidation, GSH Depletion, and SLC7A11 Inhibition Are Common Causes of EMT and Ferroptosis in A549 Cells, but Different in Specific Mechanisms
13天前
已完结
-
Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies
15天前
已关闭
-
Use of pharmacokinetic versus pharmacodynamic endpoints to support human dose predictions: implications for rational drug design and early clinical development
16天前
已完结
-
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
21天前
已完结
-
Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase
1个月前
已完结
-
Glutathione-S-transferase pi expression and activity is increased in colonic neoplasia
1个月前
已关闭
-
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
1个月前
已完结
-
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
1个月前
已完结
-
Paclitaxel in colon cancer management: from conventional chemotherapy to advanced nanocarrier delivery systems
1个月前
已完结